PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 86 filers reported holding PASSAGE BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,430 | -83.8% | 1,761 | -85.1% | 0.00% | – |
Q3 2022 | $15,000 | +275.0% | 11,849 | +760.5% | 0.00% | – |
Q1 2022 | $4,000 | -97.0% | 1,377 | -93.5% | 0.00% | – |
Q4 2021 | $134,000 | +1118.2% | 21,123 | +1872.3% | 0.00% | – |
Q3 2021 | $11,000 | -89.2% | 1,071 | -86.1% | 0.00% | – |
Q2 2021 | $102,000 | -85.9% | 7,690 | -81.5% | 0.00% | – |
Q1 2021 | $725,000 | +1379.6% | 41,464 | +2061.8% | 0.00% | – |
Q4 2020 | $49,000 | -61.1% | 1,918 | -58.4% | 0.00% | – |
Q2 2020 | $126,000 | – | 4,613 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,959,769 | $6,844,481 | 14.16% |
Lynx1 Capital Management LP | 3,355,917 | $4,631,165 | 4.00% |
New Leaf Venture Partners, L.L.C. | 2,497,922 | $3,447,132 | 2.50% |
BML Capital Management, LLC | 337,467 | $465,704 | 0.44% |
Frazier Life Sciences Management, L.P. | 3,756,915 | $5,184,543 | 0.32% |
Orbimed Advisors | 8,931,999 | $12,326,159 | 0.24% |
Newtyn Management, LLC | 790,000 | $1,090,200 | 0.22% |
Oasis Management Co Ltd. | 240,000 | $331,200 | 0.07% |
Rubric Capital Management LP | 822,105 | $1,134,505 | 0.05% |
Marquette Asset Management, LLC | 67,101 | $92,599 | 0.03% |